Wolff T, Distlerath L M, Worthington M T, Guengerich F P
Arch Toxicol. 1987;60(1-3):89-90. doi: 10.1007/BF00296955.
Polyclonal antibodies raised toward a debrisoquine 4-hydroxylating cytochrome P-450 species purified from rat liver (P-450UT-A) were used to determine which monooxygenase reactions are linked to debrisoquine hydroxylation in human liver. Anti P-450UT-A did not inhibit the oxidation of dimethylnitrosamine, morphine, diazepam, vinylidene chloride, trichloroethylene, benzo(a)pyrene and its 7.8-dihydrodiol, but was inhibitory for the hydroxylation of debrisoquine, (+/-)-bufuralol, lasiocarpine and monocrotaline. A model interpreting the substrate specificity of the human liver enzyme is presented.
用针对从大鼠肝脏中纯化出的异喹胍4-羟化细胞色素P-450同工酶(P-450UT-A)制备的多克隆抗体,来确定人肝脏中哪些单加氧酶反应与异喹胍羟基化有关。抗P-450UT-A抗体不抑制二甲基亚硝胺、吗啡、地西泮、偏二氯乙烯、三氯乙烯、苯并(a)芘及其7,8-二氢二醇的氧化,但对异喹胍、(±)-布非洛尔、毛果天芥菜碱和野百合碱的羟基化有抑制作用。本文提出了一个解释人肝脏酶底物特异性的模型。